88 related articles for article (PubMed ID: 20381105)
21. Does the GH-IGF axis play a role in cancer pathogenesis?
Cohen P; Clemmons DR; Rosenfeld RG
Growth Horm IGF Res; 2000 Dec; 10(6):297-305. PubMed ID: 11161960
[TBL] [Abstract][Full Text] [Related]
22. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
[TBL] [Abstract][Full Text] [Related]
23. Effect of tamoxifen on GH and IGF-1 serum level in stage I-II breast cancer patients.
Mandalà M; Moro C; Ferretti G; Calabro MG; Nolè F; Rocca A; Munzone E; Castro A; Curigliano G
Anticancer Res; 2001; 21(1B):585-8. PubMed ID: 11299809
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of hormone receptor expression for use in predicting survival of female dogs with malignant mammary gland tumors.
Chang CC; Tsai MH; Liao JW; Chan JP; Wong ML; Chang SC
J Am Vet Med Assoc; 2009 Aug; 235(4):391-6. PubMed ID: 19681719
[TBL] [Abstract][Full Text] [Related]
25. Elevated levels of circulating insulin-like growth factor-I, IGF-binding globulin-3 and testosterone predict hormone-dependent breast cancer in postmenopausal women: a case-control study.
Kahán Z; Gardi J; Nyári T; Földesi I; Hajnal-Papp R; Ormándi K; Lázár G; Thurzó L; Schally AV
Int J Oncol; 2006 Jul; 29(1):193-200. PubMed ID: 16773200
[TBL] [Abstract][Full Text] [Related]
26. NT-proBNP, IGF-I and survival in patients with chronic heart failure.
Petretta M; Colao A; Sardu C; Scopacasa F; Marzullo P; Pivonello R; Fontanella L; de Caterina M; de Simone A; Bonaduce D
Growth Horm IGF Res; 2007 Aug; 17(4):288-96. PubMed ID: 17383209
[TBL] [Abstract][Full Text] [Related]
27. Insulin-like growth factor (IGF)-I and IGF-II serum concentrations in patients with benign and malignant breast lesions: free IGF-II is correlated with breast cancer size.
Singer CF; Mogg M; Koestler W; Pacher M; Marton E; Kubista E; Schreiber M
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4003-9. PubMed ID: 15217931
[TBL] [Abstract][Full Text] [Related]
28. Ovariectomy during the luteal phase influences secretion of prolactin, growth hormone, and insulin-like growth factor-I in the bitch.
Lee WM; Kooistra HS; Mol JA; Dieleman SJ; Schaefers-Okkens AC
Theriogenology; 2006 Jul; 66(2):484-90. PubMed ID: 16442609
[TBL] [Abstract][Full Text] [Related]
29. The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer.
Rhee J; Han SW; Oh DY; Kim JH; Im SA; Han W; Park IA; Noh DY; Bang YJ; Kim TY
BMC Cancer; 2008 Oct; 8():307. PubMed ID: 18947390
[TBL] [Abstract][Full Text] [Related]
30. A comparative study of canine and human breast cancer.
Owen LN
Invest Cell Pathol; 1979; 2(4):257-75. PubMed ID: 396282
[TBL] [Abstract][Full Text] [Related]
31. Expression of insulin-like growth factor-1 by canine insulinomas and their metastases.
Buishand FO; van Erp MG; Groenveld HA; Mol JA; Kik M; Robben JH; Kooistra HS; Kirpensteijn J
Vet J; 2012 Mar; 191(3):334-40. PubMed ID: 21507690
[TBL] [Abstract][Full Text] [Related]
32. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
[TBL] [Abstract][Full Text] [Related]
33. Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.
Pekonen F; Partanen S; Mäkinen T; Rutanen EM
Cancer Res; 1988 Mar; 48(5):1343-7. PubMed ID: 2963690
[TBL] [Abstract][Full Text] [Related]
34. Correlation between longitudinal bone growth, growth hormone, and insulin-like growth factor-I in prepubertal dogs.
Conzemius MG; Brown DC; Brabec M; Smith GK; Washabau R; LaFond E; Chakraborty PK
Am J Vet Res; 1998 Dec; 59(12):1608-12. PubMed ID: 9858415
[TBL] [Abstract][Full Text] [Related]
35. Effect of dietary energy and somatotropin on components of the somatotropic axis in Holstein heifers.
Radcliff RP; VandeHaar MJ; Kobayashi Y; Sharma BK; Tucker HA; Lucy MC
J Dairy Sci; 2004 May; 87(5):1229-35. PubMed ID: 15290971
[TBL] [Abstract][Full Text] [Related]
36. Investigation of the local expression of the relaxin system in canine mammary tumours.
Lamp O; Honscha KU; Jakob J; Lamp J; Schweizer S; Reischauer A; Gottschalk J; Hahn A; Ebert M; Rothemund S; Blaschzik S; Einspanier A
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():224-9. PubMed ID: 19754574
[TBL] [Abstract][Full Text] [Related]
37. Identification of prognostic factors in canine mammary malignant tumours: a multivariable survival study.
Santos AA; Lopes CC; Ribeiro JR; Martins LR; Santos JC; Amorim IF; Gärtner F; Matos AJ
BMC Vet Res; 2013 Jan; 9():1. PubMed ID: 23289974
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of pulsatile plasma concentrations of growth hormone in healthy dogs and dogs with dilated cardiomyopathy.
Beijerink NJ; Lee WM; Stokhof AA; Voorhout G; Mol JA; Kooistra HS
Am J Vet Res; 2011 Jan; 72(1):59-63. PubMed ID: 21194336
[TBL] [Abstract][Full Text] [Related]
39. Clinical value of carcinoembryonic antigen in mammary neoplasms of bitches.
Senhorello ILS; Terra EM; Sueiro FAR; Firmo BF; Anai LA; Goloni C; Canavari IC; Ampuero RAN; Pereira RS; Tinucci-Costa M
Vet Comp Oncol; 2020 Sep; 18(3):315-323. PubMed ID: 31664787
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical study of IGF-I and IGF-II expression in canine mammary tumours: Prognostic and diagnostic role.
Ozmen O
Acta Vet Hung; 2020 Sep; 68(3):269-274. PubMed ID: 33221734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
